Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples